Globus Medical (GMED) Free Cash Flow (2011 - 2026)

Globus Medical's Free Cash Flow history runs 16 years deep, the most recent figure standing at $162.7 million for Q1 2026.

• Quarterly Free Cash Flow rose 15.26% year-over-year to $162.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $610.3 million (down 2.93% YoY) and the FY2025 annual result came in at $588.8 million, up 15.14% from the prior year.
• Free Cash Flow was $162.7 million for Q1 2026 at Globus Medical, down from $202.4 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $299.4 million in Q4 2024 and bottomed at $7.7 million in Q2 2023.
• A 5-year average of $90.1 million and a median of $46.8 million in 2023 frame the typical range for Free Cash Flow.
• Annual changes were most pronounced in 2022 — Free Cash Flow tumbled 77.47% — and 2025, when it jumped 492.79%.
• Globus Medical's Free Cash Flow stood at $45.6 million in 2022, then jumped by 79.23% to $81.8 million in 2023, then surged by 266.02% to $299.4 million in 2024, then sank by 32.4% to $202.4 million in 2025, then decreased by 19.59% to $162.7 million in 2026.
• Business Quant data shows GMED's Free Cash Flow at $162.7 million in Q1 2026, $202.4 million in Q4 2025, and $144.7 million in Q3 2025.